{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T16:44:29Z","timestamp":1772815469163,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,1,17]],"date-time":"2012-01-17T00:00:00Z","timestamp":1326758400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s10461-012-0136-y","type":"journal-article","created":{"date-parts":[[2012,1,16]],"date-time":"2012-01-16T12:10:47Z","timestamp":1326715847000},"page":"68-73","source":"Crossref","is-referenced-by-count":18,"title":["Injection Drug Use and HIV Antiretroviral Therapy Discontinuation in A Canadian Setting"],"prefix":"10.1007","volume":"17","author":[{"given":"Dan","family":"Werb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-J.","family":"Milloy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"Montaner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,1,17]]},"reference":[{"issue":"9651","key":"136_CR1","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0140-6736(08)61311-2","volume":"372","author":"BM Mathers","year":"2008","unstructured":"Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008;372(9651):1733\u201345.","journal-title":"Lancet"},{"key":"136_CR2","volume-title":"Illicit drug policies and the global HIV epidemic: effects of UN and national government approaches. Report","author":"D Wolfe","year":"2004","unstructured":"Wolfe D, Malinowska-Sempruch K. Illicit drug policies and the global HIV epidemic: effects of UN and national government approaches. Report. New York: Open Society Institute; 2004."},{"key":"136_CR3","first-page":"2008","volume-title":"Report on the global AIDS epidemic","author":"UNAIDS","year":"2008","unstructured":"UNAIDS. Report on the global AIDS epidemic. Geneva: Joint United Nations Programme on HIV\/AIDS; 2008. p. 2008."},{"key":"136_CR4","volume-title":"WHO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users","author":"M Donoghoe","year":"2009","unstructured":"Donoghoe M, Verster AD, Mathers B. WHO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users. Geneva: WHO\/UNODC\/UNAIDS; 2009."},{"issue":"3","key":"136_CR5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/09540120903193757","volume":"22","author":"J Dewhurst","year":"2010","unstructured":"Dewhurst J. HIV Preventing infection among injecting drug users in high-risk countries: an assessment of the evidence. AIDS Care. 2010;22(3):397.","journal-title":"AIDS Care."},{"issue":"1","key":"136_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugpo.2005.08.003","volume":"16","author":"A Ball","year":"2005","unstructured":"Ball A, Beg M, Doupe A, Weiler G. Evidence for action: a critical tool for guiding policies and programmes for HIV prevention, treatment and care among injecting drug users. Int J Drug Pol. 2005;16(1):1\u20136.","journal-title":"Int J Drug Pol."},{"issue":"14","key":"136_CR7","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1001\/jama.2010.421","volume":"303","author":"ND Volkow","year":"2010","unstructured":"Volkow ND, Montaner J. Enhanced HIV testing, treatment, and support for HIV-infected substance users. JAMA. 2010;303(14):1423.","journal-title":"JAMA."},{"key":"136_CR8","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/4631006a","volume":"463","author":"EC Hayden","year":"2010","unstructured":"Hayden EC. \u2018Seek, test and treat\u2019 slows HIV. Nature. 2010;463:1006.","journal-title":"Nature."},{"key":"136_CR9","unstructured":"Oka S. Treatment 2.0 Fact Sheet. Geneva: UNAIDS, 2010."},{"key":"136_CR10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1758-2652-12-16","volume":"12","author":"CK Jha","year":"2009","unstructured":"Jha CK, Madison J. Disparity in health care: HIV, stigma, and marginalization in Nepal. J Int AIDS Soc. 2009;12:16.","journal-title":"J Int AIDS Soc."},{"issue":"3","key":"136_CR11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/QAD.0b013e328011cb20","volume":"21","author":"SCJM Vervoort","year":"2007","unstructured":"Vervoort SCJM, Borleffs JCC, Hoepelman AIM, Grypdonck MHF. Adherence in antiretroviral therapy: a review of qualitative studies. AIDS. 2007;21(3):271.","journal-title":"AIDS."},{"issue":"11","key":"136_CR12","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1371\/journal.pmed.0030438","volume":"3","author":"EJ Mills","year":"2006","unstructured":"Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, Wu P, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med. 2006;3(11):e438.","journal-title":"PLoS Med."},{"issue":"8","key":"136_CR13","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/j.1360-0443.2008.02269.x","volume":"103","author":"M Malta","year":"2008","unstructured":"Malta M, Strathdee S, Magnanini MMF, Bastos FI. Adherence to antiretroviral therapy for human immunodeficiency virus\/acquired immune deficiency syndrome among drug users: a systematic review. Addiction. 2008;103(8):1242\u201357.","journal-title":"Addiction."},{"issue":"11","key":"136_CR14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/QAD.0b013e3282fbd1ed","volume":"22","author":"E Wood","year":"2008","unstructured":"Wood E, Kerr T, Tyndall MW, Montaner JSG. A review of barriers and facilitators of HIV treatment among injection drug users. AIDS. 2008;22(11):9.","journal-title":"AIDS."},{"issue":"1","key":"136_CR15","first-page":"S61","volume":"13","author":"GH Friedland","year":"1999","unstructured":"Friedland GH, Williams A. Attaining higher goals in HIV treatment: the central importance of adherence. AIDS. 1999;13(1):S61\u201372.","journal-title":"AIDS."},{"issue":"2","key":"136_CR16","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.drugalcdep.2006.02.003","volume":"84","author":"A Palepu","year":"2006","unstructured":"Palepu A, Tyndall MW, Joy R, Kerr T, Wood E, Press N, et al. Antiretroviral adherence and HIV treatment outcomes among HIV\/HCV co-infected injection drug users: the role of methadone maintenance therapy. Drug Alc Depend. 2006;84(2):188\u201394.","journal-title":"Drug Alc Depend."},{"issue":"6","key":"136_CR17","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1001\/jama.280.6.547","volume":"280","author":"SA Strathdee","year":"1998","unstructured":"Strathdee SA, Palepu A, Cornelisse PG, Yip B, O\u2019Shaughnessy MV, Montaner JS, et al. Barriers to use of free antiretroviral therapy in injection drug users. JAMA. 1998;280(6):547.","journal-title":"JAMA."},{"issue":"10","key":"136_CR18","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.292.10.1175-b","volume":"292","author":"E Wood","year":"2004","unstructured":"Wood E, Hogg RS, Bonner S, Kerr T, Li K, Palepu A, et al. Staging for antiretroviral therapy among HIV-infected drug users. JAMA. 2004;292(10):1175.","journal-title":"JAMA."},{"issue":"3","key":"136_CR19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/135965350400900314","volume":"9","author":"T Kerr","year":"2004","unstructured":"Kerr T, Palepu A, Barness G, Walsh J, Hogg R, Montaner J, et al. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver. Antivir Ther. 2004;9(3):407.","journal-title":"Antivir Ther."},{"issue":"5","key":"136_CR20","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/09540120412331319778","volume":"17","author":"T Kerr","year":"2005","unstructured":"Kerr T, Marshall A, Walsh J, Palepu A, Tyndall M, Montaner J, et al. Determinants of HAART discontinuation among injection drug users. AIDS Care. 2005;17(5):539.","journal-title":"AIDS Care."},{"issue":"8","key":"136_CR21","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/jech.2004.030759","volume":"59","author":"JWR Twisk","year":"2005","unstructured":"Twisk JWR, Smidt N, de Vente W. Applied analysis of recurrent events: a practical overview. J Epidemiol Community Health. 2005;59(8):706.","journal-title":"J Epidemiol Community Health"},{"issue":"5","key":"136_CR22","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/00002030-200303280-00009","volume":"17","author":"E Wood","year":"2003","unstructured":"Wood E, Hogg RS, Yip B, Harrigan PR, O\u2019Shaughnessy MV, Montaner JS. Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy? AIDS. 2003;17(5):711.","journal-title":"AIDS."},{"issue":"7","key":"136_CR23","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1473-3099(10)70097-9","volume":"10","author":"D Werb","year":"2010","unstructured":"Werb D, Mills EJ, Montaner JSG, Wood E. Risk of resistance to highly active antiretroviral therapy among HIV-positive injecting drug users: a meta-analysis. Lancet Inf Dis. 2010;10(7):464\u20139.","journal-title":"Lancet Inf Dis."},{"key":"136_CR24","unstructured":"WHO. WHO, HIV\/AIDS treatment and care for injecting drug users: Clinical protocol for the WHO European region. WHO Regional Office for Europe: Copenhagen; 2006."},{"key":"136_CR25","volume-title":"Panel on antiretroviral guidelines for adults and adolescents: Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents","author":"Department of Health and Human Services","year":"2008","unstructured":"Department of Health and Human Services. Panel on antiretroviral guidelines for adults and adolescents: Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Washington: Department of Health and Human Services; 2008."},{"key":"136_CR26","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1097\/QAI.0b013e318209751e","volume":"56","author":"FL Altice","year":"2011","unstructured":"Altice FL, Bruce RD, Lucas GM, Lum PJ, Korthuis PT, Flanigan TP, et al. HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine\/naloxone treatment within HIV clinical care settings: results from a multisite study. JAIDS. 2011;56:S22.","journal-title":"JAIDS."},{"issue":"1","key":"136_CR27","first-page":"1","volume":"287","author":"LM Stevens","year":"2002","unstructured":"Stevens LM. Cocaine addiction. JAMA. 2002;287(1):1.","journal-title":"JAMA."},{"issue":"1","key":"136_CR28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/jech.2007.069013","volume":"63","author":"K DeBeck","year":"2009","unstructured":"DeBeck K, Small W, Wood E, Li K, Montaner J, Kerr T. Public injecting among a cohort of injecting drug users in Vancouver Canada. J Epidemiol Community Health. 2009;63(1):81\u20136.","journal-title":"J Epidemiol Community Health"},{"issue":"10","key":"136_CR29","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/j.1360-0443.2006.01556.x","volume":"101","author":"T Rhodes","year":"2006","unstructured":"Rhodes T, Kimber J, Small W, Fitzgerald J, Kerr T, Hickman M, et al. Public injecting and the need for \u201csafer environment interventions\u201d in the reduction of drug-related harm. Addiction. 2006;101(10):1384.","journal-title":"Addiction"},{"issue":"1","key":"136_CR30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.drugpo.2006.11.019","volume":"18","author":"W Small","year":"2007","unstructured":"Small W, Rhodes T, Wood E, Kerr T. Public injection settings in Vancouver: physical environment, social context and risk. Int J Drug Pol. 2007;18(1):27\u201336.","journal-title":"Int J Drug Pol."},{"issue":"9","key":"136_CR31","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2893.2007.00855.x","volume":"14","author":"M Hickman","year":"2007","unstructured":"Hickman M, Hope V, Brady T, Madden P, Jones S, Honor S, et al. Hepatitis C virus (HCV) prevalence, and injecting risk behaviour in multiple sites in England in 2004. J Viral Hepatitis. 2007;14(9):645\u201352.","journal-title":"J Viral Hepatitis"},{"issue":"1","key":"136_CR32","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2334-8-120","volume":"8","author":"V Hope","year":"2008","unstructured":"Hope V, Kimber J, Vickerman P, Hickman M, Ncube F. Frequency, factors and costs associated with injection site infections: findings from a national multi-site survey of injecting drug users in England. BMC Infect Dis. 2008;8(1):120.","journal-title":"BMC Infect Dis."},{"issue":"1","key":"136_CR33","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1753-6405.2008.00163.x","volume":"32","author":"L Topp","year":"2008","unstructured":"Topp L, Iversen J, Conroy A, Salmon AM, Maher L. Prevalence and predictors of injecting related injury and disease among clients of Australia\u2019s needle and syringe programs. Aust N Z J Public Health. 2008;32(1):34\u20137.","journal-title":"Aust N Z J Public Health"},{"issue":"2","key":"136_CR34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.drugpo.2005.12.005","volume":"17","author":"W Small","year":"2006","unstructured":"Small W, Kerr T, Charette J, Schechter M, Spittal PM. Impacts of intensified police activity on injection drug users: Evidence from an ethnographic investigation. Int J Drug Pol. 2006;17(2):85.","journal-title":"Int J Drug Pol."},{"issue":"1","key":"136_CR35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1477-7517-7-6","volume":"7","author":"E Lloyd-Smith","year":"2010","unstructured":"Lloyd-Smith E, Rachlis BS, Tobin D, Stone D, Li K, Small W, et al. Assisted injection in outdoor venues: an observational study of risks and implications for service delivery and harm reduction programming. Harm Reduct J. 2010;7(1):6.","journal-title":"Harm Reduct J."}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-012-0136-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10461-012-0136-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-012-0136-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T17:18:42Z","timestamp":1686676722000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10461-012-0136-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,17]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["136"],"URL":"https:\/\/doi.org\/10.1007\/s10461-012-0136-y","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,17]]}}}